• Study Comparing Subcutaneous and Intravenous Nivolumab and Relatlimab for Patients with Untreated Metastatic or Unresectable Melanoma

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Finland France Germany +5
  • Study on Semaglutide for Reducing Mucositis in Patients Undergoing High-Dose Chemotherapy with Stem Cell Transplantation

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark
  • Study on Dostarlimab to Prevent Second Cancer in Patients Cured from Primary Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study Comparing Ebastine and Mebeverine for Treating Irritable Bowel Syndrome in Adults

    Recruiting

    3 1 1
    Investigated diseases:
    Belgium
  • Study on Patient-Controlled Sedation with Propofol for Women Undergoing Repair of Obstetric Perineal Tears Using Ropivacaine, Lidocaine, and Mepivacaine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Study of Pembrolizumab for Children with Advanced Melanoma or PD-L1 Positive Solid Tumors and Lymphoma

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Portugal Sweden
  • Study on Ewing Sarcoma Treatment with Vinorelbine and Drug Combination for Patients with Primary and Disseminated Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium Finland Germany Greece Hungary +2
  • Study on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma

    Recruiting

    3 1 1 1
    Germany Greece
  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Belgium France
  • Study on the Best Antithrombotic Therapy for Patients with Acute Venous Thromboembolism Using Tinzaparin Sodium and Drug Combination

    Recruiting

    3 1 1 1
    France

powered by